QUAISAR Drug Design Platform

WIPO WIPO 2023

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark QUAISAR Drug Design Platform was filed as Word mark on 01/20/2023 at the World Intellectual Property Organization.

Trademark Details Last update: May 5, 2023

Trademark form Word mark
File reference 1720661
Register number 789504
Countries Canada European Community United Kingdom Japan
Base trademark CH No. 789504, July 26, 2022
Application date January 20, 2023
Expiration date January 20, 2033

Trademark owner

Viaduktstrasse 8
4051 Basel
CH

Trademark representatives

151 W 42nd St, 17th Floor New York NY 10036 US

goods and services

09 Computer software; computer software for providing, analyzing and generating reports; computer software for data processing; electronic apparatus, electronic equipment, software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; computer software for database integration; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for genetic assessment and identification of diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical data and images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement
42 Scientific and technological services and research and design relating thereto; Analysis of technical data by computers; pharmaceutical drug discovery services; Pharmaceutical and biotechnology research and development services; drug use discovery services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery; conducting scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; providing scientific, pharmaceutical and agrochemical database research services; scientific and pharmaceutical artificial intelligence research services to identify molecules and compounds for drug discovery and chemical development; bioinformatics services, namely, using the combination of biology, computer science, information engineering, mathematics and statistics to analyze and interpret biological data; computer-assisted molecule design; identification of biological targets, networks and pathways; biological research and analysis; pharmaceutical research and development services; computer-aided diagnostic and screening services for scientific research purposes; contract research services in support of scientific research and development of pharmaceutical preparations; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology and biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Trademark history

Date Document number Area Entry
March 24, 2023 2023/14 Gaz EM Rejection
January 20, 2023 2023/10 Gaz CH Registration

ID: 141720661